Rxsight Net Debt from 2010 to 2024

RXST Stock

USD 46.38 1.55 3.46%

Rxsight Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Rxsight minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2010-12-31

Previous Quarter

-6.7 M

Current Value

-6.3 M

Quarterly Volatility

11.6 M

Credit Downgrade

Yuan Drop

Covid

Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 18.9 K, Net Interest Income of 3.4 M or Interest Income of 6.9 M, as well as many indicators such as Price To Sales Ratio of 14.82, Dividend Yield of 0.0 or PTB Ratio of 9.1. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.

Check out the analysis of Rxsight Correlation against competitors.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Latest Rxsight's Net Debt Growth Pattern

Below is the plot of the Net Debt of Rxsight over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Rxsight's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Rxsight Net Debt Regression Statistics

	Arithmetic Mean	2,202,867
	Geometric Mean	4,340,314
	Coefficient Of Variation	525.40
	Mean Deviation	8,517,387
	Median	(2,442,000)
	Standard Deviation	11,573,818
	Sample Variance	134T
	Range	39.8M
	R-Value	0.38
	Mean Square Error	123.5T
	R-Squared	0.14
	Significance	0.16
	Slope	981,811
	Total Sum of Squares	1875.3T

Rxsight Net Debt History

	2024	-6.3 M
	2023	-6.7 M
	2022	33.2 M
	2021	20.6 M
	2020	16.8 M

Other Fundumenentals of Rxsight

Net Debt To E B I T D A

Rxsight Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Capital Surpluse
Total Assets		0.96	0.96	0.76	0.31	-0.81	0.46	0.77	0.98	-0.95	0.96	1.0	-0.95	1.0	0.77	-0.95	-0.94	0.98	-0.54	0.67
Total Stockholder Equity	0.96		1.0	0.83	0.37	-0.92	0.47	0.88	0.91	-1.0	1.0	0.96	-0.97	0.94	0.85	-0.97	-0.98	0.99	-0.66	0.73
Net Tangible Assets	0.96	1.0		0.81	0.42	-0.9	0.45	0.85	0.91	-1.0	1.0	0.96	-0.98	0.95	0.88	-0.98	-0.99	0.99	-0.61	0.69
Current Deferred Revenue	0.76	0.83	0.81		0.18	-0.88	0.78	0.89	0.66	-0.84	0.81	0.77	-0.8	0.72	0.61	-0.8	-0.88	0.86	-0.6	0.9
Net Debt	0.31	0.37	0.42	0.18		-0.16	-0.33	0.06	0.25	-0.4	0.43	0.33	-0.32	0.32	0.76	-0.32	-0.44	0.38	0.29	-0.19
Retained Earnings	-0.81	-0.92	-0.9	-0.88	-0.16		-0.6	-0.99	-0.72	0.93	-0.91	-0.81	0.88	-0.77	-0.7	0.88	0.9	-0.88	0.85	-0.88
Accounts Payable	0.46	0.47	0.45	0.78	-0.33	-0.6		0.64	0.44	-0.48	0.43	0.47	-0.56	0.43	0.17	-0.56	-0.52	0.52	-0.49	0.8
Net Receivables	0.77	0.88	0.85	0.89	0.06	-0.99	0.64		0.67	-0.88	0.86	0.77	-0.82	0.72	0.61	-0.82	-0.86	0.85	-0.88	0.93
Short Term Investments	0.98	0.91	0.91	0.66	0.25	-0.72	0.44	0.67		-0.89	0.9	0.98	-0.92	0.99	0.72	-0.92	-0.87	0.93	-0.48	0.59
Total Liab	-0.95	-1.0	-1.0	-0.84	-0.4	0.93	-0.48	-0.88	-0.89		-1.0	-0.95	0.97	-0.93	-0.86	0.97	0.99	-0.99	0.65	-0.73
Net Invested Capital	0.96	1.0	1.0	0.81	0.43	-0.91	0.43	0.86	0.9	-1.0		0.96	-0.96	0.94	0.88	-0.96	-0.99	0.99	-0.62	0.7
Total Current Assets	1.0	0.96	0.96	0.77	0.33	-0.81	0.47	0.77	0.98	-0.95	0.96		-0.95	1.0	0.78	-0.95	-0.95	0.98	-0.54	0.68
Capital Stock	-0.95	-0.97	-0.98	-0.8	-0.32	0.88	-0.56	-0.82	-0.92	0.97	-0.96	-0.95		-0.93	-0.85	1.0	0.95	-0.96	0.6	-0.68
Net Working Capital	1.0	0.94	0.95	0.72	0.32	-0.77	0.43	0.72	0.99	-0.93	0.94	1.0	-0.93		0.76	-0.93	-0.92	0.96	-0.51	0.63
Short Term Debt	0.77	0.85	0.88	0.61	0.76	-0.7	0.17	0.61	0.72	-0.86	0.88	0.78	-0.85	0.76		-0.85	-0.87	0.83	-0.3	0.34
Common Stock	-0.95	-0.97	-0.98	-0.8	-0.32	0.88	-0.56	-0.82	-0.92	0.97	-0.96	-0.95	1.0	-0.93	-0.85		0.95	-0.96	0.6	-0.68
Property Plant Equipment	-0.94	-0.98	-0.99	-0.88	-0.44	0.9	-0.52	-0.86	-0.87	0.99	-0.99	-0.95	0.95	-0.92	-0.87	0.95		-0.99	0.57	-0.74
Long Term Debt	0.98	0.99	0.99	0.86	0.38	-0.88	0.52	0.85	0.93	-0.99	0.99	0.98	-0.96	0.96	0.83	-0.96	-0.99		-0.58	0.74
Long Term Debt Total	-0.54	-0.66	-0.61	-0.6	0.29	0.85	-0.49	-0.88	-0.48	0.65	-0.62	-0.54	0.6	-0.51	-0.3	0.6	0.57	-0.58		-0.83
Capital Surpluse	0.67	0.73	0.69	0.9	-0.19	-0.88	0.8	0.93	0.59	-0.73	0.7	0.68	-0.68	0.63	0.34	-0.68	-0.74	0.74	-0.83

Click cells to compare fundamentals

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-6.7 M	-6.3 M
Net Debt To EBITDA	0.16	0.17

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rxsight Net Debt from 2010 to 2024

Latest Rxsight's Net Debt Growth Pattern

Rxsight Net Debt Regression Statistics

Rxsight Net Debt History

Other Fundumenentals of Rxsight

Rxsight Net Debt component correlations

About Rxsight Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Rxsight Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY